‘Just the start of a wave’: The promise of mRNA cancer vaccines

Drugmakers Moderna and Merck have scored a breakthrough with a personalised mRNA cancer vaccine, after a large late-stage trial showed it outperformed the standard treatment for melanoma patients. Seth Cheetham, director of the Australian Personalised mRNA Cancer Immunotherapy Hub, explains on CNA's Asia Now how the vaccine uses the unique genetic blueprint of a patient’s tumour to teach the immune system to recognise and attack cancer cells. Subscribe to our channel here: https://cna.asia/youtubesub Visit our website: https://cna.asia Download our app: https://cna.asia/app Get our editors' picks of stories via chat apps: Telegram: https://cna.asia/telegram WhatsApp: https://cna.asia/whatsapp Follow us on these platforms: https://www.facebook.com/channelnewsasia https://www.instagram.com/channelnewsasia https://www.tiktok.com/@channelnewsasia